Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Expert Review of Vaccines|March 19, 2013
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapiesPawel Kalinski, Ravikumar Muthuswamy, Julie Urban
Vaccine|May 8, 2012
Lymphocyte-polarized dendritic cells are highly effective in inducing tumor-specific CTLsErik Berk, Ravikumar Muthuswamy, Pawel Kalinski
Methods in Molecular Biology (Clifton, N.J.)|November 27, 2009
Generation of stable Th1/CTL-, Th2-, and Th17-inducing human dendritic cellsPawel Kalinski, Eva Wieckowski, Ravikumar Muthuswamy, et al.
Oncoimmunology|November 15, 2013
IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patientsJeffrey L Wong, Ravikumar Muthuswamy, David L Bartlett, et al.
Critical Reviews in Oncology/Hematology|November 9, 2016
Migration of dendritic cells to the lymph nodes and its enhancement to drive anti-tumor responsesNarges Seyfizadeh, Ravikumar Muthuswamy, Duane A Mitchell, et al.
Cancer Research|October 26, 2011
PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environmentNatasa Obermajer, Ravikumar Muthuswamy, Kunle Odunsi, et al.
Journal for Immunotherapy of Cancer|March 26, 2015
Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attractionRavikumar Muthuswamy, Liwen Wang, Jamie Pitteroff, et al.
Future Oncology (London, England)|April 21, 2009
Dendritic cell-based therapeutic cancer vaccines: what we have and what we needPawel Kalinski, Julie Urban, Rahul Narang, et al.
Pageof 3